rac 1-Linolenoyl-3-chloropropanediol
|
- $185 - $460
- Product name: rac 1-Linolenoyl-3-chloropropanediol
- CAS: 74875-99-3
- MF: C21H35ClO3
- MW: 370.95
- EINECS:
- MDL Number:
- Synonyms:rac 1-Linolenoyl-3-chloropropanediol;(Z,Z,Z)-9,12,15-Octadecatrienoic Acid 3-Chloro-2-hydroxypropyl Ester;3-Chloro-1,2-propanediol 1-Linolenate;9,12,15-Octadecatrienoic acid, 3-chloro-2-hydroxypropyl ester, (9Z,12Z,15Z)-;3-Chloro-1,2-propanediol 1-Linolenate Standard
3 prices
Selected condition：
Brand
- TRC
- Usbiological
Package
- 10mg
- 25mg
- ManufacturerTRC
- Product numberL467700
- Product descriptionrac1-Linolenoyl-3-chloropropanediol
- Packaging25mg
- Price$185
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number288629
- Product descriptionrac 1-linolenoyl-3-chloropropanediol
- Packaging10mg
- Price$460
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number015591
- Product descriptionrac 1-Linolenoyl-3-chloropropanediol
- Packaging25mg
- Price$460
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| TRC | L467700 | rac1-Linolenoyl-3-chloropropanediol | 25mg | $185 | 2021-12-16 | Buy |
| Usbiological | 288629 | rac 1-linolenoyl-3-chloropropanediol | 10mg | $460 | 2021-12-16 | Buy |
| Usbiological | 015591 | rac 1-Linolenoyl-3-chloropropanediol | 25mg | $460 | 2021-12-16 | Buy |
Properties
Boiling point :481.2±45.0 °C(Predicted)
Density :1.005±0.06 g/cm3(Predicted)
storage temp. :-20°C Freezer, Under Inert Atmosphere
solubility :Chloroform (Slightly), Ethyl Acetate (Slightly)
pka :12.75±0.20(Predicted)
form :Oil
color :Clear Colorless
Density :1.005±0.06 g/cm3(Predicted)
storage temp. :-20°C Freezer, Under Inert Atmosphere
solubility :Chloroform (Slightly), Ethyl Acetate (Slightly)
pka :12.75±0.20(Predicted)
form :Oil
color :Clear Colorless
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|